LBA16 IMpassion130: Final OS analysis from the pivotal phase III study of atezolizumab + nab-paclitaxel vs placebo + nab-paclitaxel in previously untreated locally advanced or metastatic triple-negative breast cancer
Leisha A. Emens, Sylvia Adams, Carlos H. Barrios, Véronique Dièras, Hiroji Iwata, Sherene Loi, H. S. Rugo, Andreas Schneeweiß, Eric P. Winer, Shilpen Patel, Volkmar Henschel, A. Swat, Manika Kaul, Luciana Molinero, Jane Yuet Ching Hui, Peter Schmid
Topics & Concepts
MedicineAtezolizumabInternal medicinePlaceboPaclitaxelNab-paclitaxelMetastatic breast cancerBreast cancerPhases of clinical researchTriple-negative breast cancerOncologyGastroenterologyUrologyChemotherapyCancerImmunotherapyPembrolizumabPathologyAlternative medicineCancer Immunotherapy and BiomarkersAdvanced Breast Cancer TherapiesProstate Cancer Treatment and Research